Parkinson’s disease and Lewy Body Dementia (LBD) are two serious brain diseases that affect millions of people in the United ...

In a comprehensive Genomic Press perspective article published today, researchers from Fudan University and Shanghai ...

While most patients clinically diagnosed with Alzheimer's had evidence of cerebrospinal fluid (CSF) amyloid and tau pathology ...

have defined new biologic and clinical biomarkers for better identifying patients with different stages of Parkinson's disease and Lewy body dementia, according to a recent study published in npj ...

Parkinson’s disease (PD) and Lewy body dementia (LBD) are incurable and progressive neurodegenerative disorders, with some overlapping symptoms. An estimated 10 million people worldwide live with PD, ...

Neurologist Dr Bing has issued a warning to anyone who regularly experiences three sleep habits, as he urges them to speak to ...

Uncover the connection between fuzzy coats and neurodegenerative disorders such as Parkinson's disease and Lewy body dementia ...

dementia with Lewy body, and frontotemporal dementia. The key points of clinical differences of these dementia syndromes are summarized in this article. Prevalence of dementia is increasing due to ...

Researchers have identified a key enzyme driving forms of Parkinson’s disease, highlighting a promising new target for ...

Researchers have discovered a new biomarker for Parkinson's disease. A misfolded protein facilitates reliable diagnosis even in the early stages of Parkinson's disease in body fluids.

New review reveals Lewy Body Dementia research in Latin America is significantly underrepresented, with major gaps in ...